DEROXAT 20 mg/10 ml, oral suspension bottle, 150 ml
Brand page: Deroxat (paroxetine) — all forms and strengths in France
Active ingredients: Paroxetine hydrochloride hemihydrate, Paroxetine
Commercialized according to BDPMDispensing in France: Prescription only
Oral suspensionbottle, 150 mlorale
No current ANSM shortage notice is included
Package details
Original BDPM fields are shown in French.
- Official name
- DEROXAT 20 mg/10 ml, suspension buvable
- Pharmaceutical form
- suspension buvable
- Route of administration
- orale
- Presentation description
- 1 flacon(s) en verre brun de 150 ml avec fermeture de sécurité enfant avec gobelet(s) doseur(s) polypropylène
- Marketing authorisation holder
- GLAXOSMITHKLINE
- Reimbursement according to BDPM
- 65%
- Approval for use in healthcare institutions
- non
- Commercialization declaration date
- 8 Apr 2022
- Prescription and dispensing conditions
- Prescription only
- List I: prescription-only medicine
- Enhanced ANSM monitoring
- No
BDPM identifiers
CIS
65760638CIP73492860CIP133400934928604Composition in BDPM
| Component | Amount per unit | Source type |
|---|---|---|
| CHLORHYDRATE DE PAROXÉTINE HÉMIHYDRATÉsuspension | — | SA |
| PAROXÉTINE BASEsuspension | 20 mg · 10 ml de suspension buvable | FT |
Information is based on BDPM data and is for reference only. Consult a doctor before use.
Similar medicines
Similar medicines are listed using the official BDPM catalog. Availability must be checked separately. Consult a doctor or pharmacist before switching medicines.
The current BDPM data does not list similar medicines for this product.